This inventor holds 24 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 3 EPO patents, primarily in Vaccine Development. Top assignees: Glaxosmithkline Biologicals Sa, Smithkline Beecham Biologicals S.a.. Active years: 2003-2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Limal, BE (2003 - 2010)
- Rixensart, BE (2004 - 2016)
Company Filing History:
13 out of 545 
11 out of 75 Years Active: 2003-2016
Areas of Expertise:
Title: Innovations and Contributions of Jean-Louis Ruelle
Introduction
Jean-Louis Ruelle, an acclaimed inventor based in Limal, Belgium, has made significant contributions to the field of biotechnology. With an impressive portfolio of 24 patents, Ruelle's work primarily focuses on the development of vaccines and therapeutic compounds, demonstrating his commitment to advancing medical science and enhancing public health.
Latest Patents
Ruelle's latest patents include breakthroughs in recombinant respiratory syncytial virus (RSV) vaccines. His disclosure detail methods for creating recombinant RSV antigens, which are essential for developing immunogenic compositions, including vaccines aimed at preventing RSV infections. Furthermore, his patents encompass novel compounds such as BASB082, BASB083, BASB091, BASB092, and BASB101. These inventions involve polypeptides and polynucleotides encoded by these compounds, alongside methods for their production via recombinant techniques, presenting various diagnostic, prophylactic, and therapeutic applications.
Career Highlights
Throughout his career, Jean-Louis Ruelle has worked with leading companies in the pharmaceutical sector, including GlaxoSmithKline Biologicals SA and SmithKline Beecham Biologicals SA. His experience in these organizations has significantly influenced his research, enabling him to contribute effectively to vaccine development and biotechnology innovations.
Collaborations
Ruelle has collaborated with esteemed colleagues such as Catherine Defrenne and Christine Delmelle. These partnerships have fostered an environment of innovation and creativity, promoting the exploration of new ideas and solutions in biotechnology.
Conclusion
Jean-Louis Ruelle's dedication to his work has resulted in pioneering patents that shape the future of vaccine development and therapeutic interventions. His consistent drive for innovation showcases the vital role of inventors in addressing global health challenges, making him a distinguished figure in the biotechnology sector.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile